Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angola
100%
Benguela
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
55%
Capsid Inhibitor
50%
Lenacapavir
50%
Genetic Diversity
50%
Capsid Protein
50%
Protein-coding Genes
50%
Primary Resistance
50%
General Hospital
42%
HIV-1 Genetic Diversity
37%
Resistance mutations
30%
Infection Rate
25%
Rapid Plasma Reagin
25%
Treponema Pallidum
25%
Transmitted Resistance
25%
Integrase Strand Transfer Inhibitor (INSTI)
25%
Unique Recombinant Forms
17%
Recombinant Form
17%
Nave
17%
Maximum Likelihood Method
17%
Blood Samples
17%
Antiretroviral Therapy
17%
Genetic Constructs
17%
Treponema Pallidum Hemagglutination Assay
14%
HIV DNA
12%
Gag Gene
12%
Central Africa
12%
Antiviral Drugs
12%
Sub-Saharan Africa
12%
Capsid
12%
Southern Africa
12%
Associated Complications
12%
Antiretroviral
12%
AIDS-related
12%
Phylogenetic Analysis
12%
Molecular Epidemiology
12%
HIV Patients
12%
HIV-1 Infection
12%
Integrase
10%
Human Immunodeficiency Virus Infection
7%
Syphilis
7%
Treponemal Tests
7%
Genome Complexity
5%
Dolutegravir
5%
Sanger Method
5%
Coding Region
5%
Transmitted Drug Resistance
5%
Continued Use
5%
Major mutations
5%
Medicine and Dentistry
Human immunodeficiency virus
62%
Capsid Protein
50%
Genetic Variability
50%
Virus Capsid
50%
Treponema pallidum
25%
Infection Rate
25%
Red Cell Agglutination
16%
Rapid Plasma Reagin
16%
Resistance Mutation
14%
Reagin Test
12%
Infection
12%
Mixed Infection
12%
Syphilis
8%
Pandemic
7%
Human Immunodeficiency Virus 1 Infection
7%
Maximum Likelihood Method
7%
Recombinant DNA
7%
Structural Gene
7%
Molecular Epidemiology
7%
Aciclovir
7%
Antiretroviral Therapy
7%
Immunology and Microbiology
Genetic Variability
75%
Human Immunodeficiency Virus 1
75%
Capsid
50%
Integrase
25%
Human immunodeficiency virus
12%
Cladistics
12%
Structural Gene
7%
Infection
7%
Molecular Epidemiology
7%
Drug Resistance
5%
Prevalence
5%
Dideoxynucleotide Sequencing
5%